<DOC>
	<DOC>NCT00044720</DOC>
	<brief_summary>The incidence of efficacy failure at 12 months between two regimens.</brief_summary>
	<brief_title>Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Graft vs Host Disease</mesh_term>
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Inclusion Criteria Age: 13 years or older, 40 kgs or more Endstage renal disease AfricanAmerican/Black transplant recipient and/or repeat renal transplant recipient who lost a previous allograft Exclusion Criteria Evidence of active infection Evidence abnormal chest xray Patients with HIV.</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Kidney Transplant</keyword>
</DOC>